Filana Therapeutics, Inc. Accounts Payable
Filana Therapeutics, Inc. (FLNA) had Accounts Payable of $10.34 million as of 2023-06-30, per its 10-Q filed 2023-08-03.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2023-08-03
- 2023-06-30: Accounts Payable, Current $10.34M.
- 2023-03-31: Accounts Payable, Current $8.24M.
- 2022-12-31: Accounts Payable, Current $4.02M.
- 2022-09-30: Accounts Payable, Current $3.53M.
| Period end | Accounts Payable, Current |
|---|---|
| 2023-06-30 | $10.34M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $8.24M 10-Q · filed 2023-05-01 |
| 2022-12-31 | $4.02M 10-Q · filed 2023-08-03 |
| 2022-09-30 | $3.53M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $4.76M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $3.33M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $7.13M 10-K · filed 2023-02-28 |
| 2021-09-30 | $2.35M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $1.91M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $864.00K 10-Q · filed 2021-04-29 |
| 2020-12-31 | $911.00K 10-K · filed 2022-03-01 |
| 2020-09-30 | $465.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $416.00K 10-Q · filed 2020-08-12 |
| 2020-03-31 | $608.00K 10-Q · filed 2020-05-06 |
| 2019-12-31 | $453.00K 10-K · filed 2021-03-23 |
| 2019-09-30 | $340.00K 10-Q · filed 2019-10-29 |
| 2019-06-30 | $594.00K 10-Q · filed 2019-08-12 |
| 2019-03-31 | $495.00K 10-Q · filed 2019-05-02 |
| 2018-12-31 | $294.00K 10-K · filed 2020-03-26 |
| 2018-09-30 | $549.00K 10-Q · filed 2018-10-30 |
| 2018-06-30 | $962.00K 10-Q · filed 2018-07-26 |
| 2018-03-31 | $421.00K 10-Q · filed 2018-05-09 |
| 2017-12-31 | $424.00K 10-K · filed 2019-03-29 |
| 2017-09-30 | $712.00K 10-Q · filed 2017-11-01 |
| 2017-06-30 | $658.00K 10-Q · filed 2017-08-09 |
| 2017-03-31 | $573.00K 10-Q · filed 2017-04-26 |
| 2016-12-31 | $303.00K 10-K · filed 2018-02-06 |
| 2016-09-30 | $1.08M 10-Q · filed 2016-10-26 |
| 2016-06-30 | $378.00K 10-Q · filed 2016-07-19 |
| 2016-03-31 | $1.04M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $1.03M 10-K · filed 2017-03-07 |
| 2015-09-30 | $898.00K 10-Q · filed 2015-11-09 |
| 2015-06-30 | $465.00K 10-Q · filed 2015-07-23 |
| 2015-03-31 | $255.00K 10-Q · filed 2015-05-08 |
| 2014-12-31 | $173.00K 10-K · filed 2016-03-03 |
| 2014-09-30 | $822.00K 10-Q · filed 2014-11-05 |
| 2014-06-30 | $360.00K 10-Q · filed 2014-08-06 |
| 2014-03-31 | $428.00K 10-Q · filed 2014-05-07 |
| 2013-12-31 | $445.00K 10-K · filed 2015-02-18 |
| 2013-09-30 | $531.00K 10-Q · filed 2013-11-01 |
| 2013-06-30 | $435.00K 10-Q · filed 2013-08-01 |
| 2013-03-31 | $366.00K 10-Q · filed 2013-04-24 |
| 2012-12-31 | $361.00K 10-K · filed 2014-02-05 |
| 2012-09-30 | $507.00K 10-Q · filed 2012-11-09 |
| 2012-06-30 | $501.00K 10-Q · filed 2012-08-02 |
| 2012-03-31 | $502.00K 10-Q · filed 2012-05-08 |
| 2011-12-31 | $464.00K 10-K · filed 2013-02-08 |
| 2011-09-30 | $556.00K 10-Q · filed 2011-11-03 |
| 2011-06-30 | $604.00K 10-Q · filed 2011-08-04 |
| 2010-12-31 | $1.11M 10-K · filed 2012-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |